ArticleOncotarget2017

Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas.

Yangkyu Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.